z-logo
open-access-imgOpen Access
Poly (ɛ‐caprolactone)–chitosan–poly (vinyl alcohol) nanofibrous scaffolds for skin excisional and burn wounds in a canine model
Author(s) -
GholipourKanani Adeleh,
Mohsenzadegan Monireh,
Fayyazi Mohammadreza,
Bahrami Hajir,
Samadikuchaksaraei Ali
Publication year - 2018
Publication title -
iet nanobiotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.366
H-Index - 38
eISSN - 1751-875X
pISSN - 1751-8741
DOI - 10.1049/iet-nbt.2017.0115
Subject(s) - vinyl alcohol , wound healing , biomedical engineering , chitosan , immunogenicity , materials science , chemistry , surgery , immune system , medicine , composite material , polymer , immunology , biochemistry
Poly (ɛ‐caprolactone)–chitosan–poly (vinyl alcohol) (PCL: Cs: PVA) nanofibrous blend scaffolds were known as useful materials for skin wound healing and would help the healing process about 50% faster at the final time point. From the previous studies by the authors, PCL: Cs: PVA (in 2: 1: 1.5 mass ratio) nanofibres showed high efficacy in healing on rat models. In this study, the scaffolds were examined in burn and excision wounds healing on dogs as bigger models. The scaffolds were applied on dorsum skin wounds ( n  = 5) then macroscopic and microscopic investigations were carried out to measure the wounds areas and to track healing rate, respectively. Macroscopic results showed good aspect healing effect of scaffolds compared with control wounds especially after 21 days post‐operating for both cutting and burn wounds. Pathological studies showed that the healing rates of the wounds covered with PCL: Cs: PVA nanofibrous scaffolds were much rapid compared to untreated wounds in control group. The immunogenicity of the scaffolds in canine model was also investigated. The findings showed that nanofibrous blend scaffolds was not immunogenic in humoural immune responses. All these results indicated that PCL: Cs: PVA nanofibrous web could be considered as promising materials for wounds healings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here